FULL POSTER SESSION ABSTRACTSproblem is that, although the effectiveness of P. gigantea as a bio-control agent has empirically been shown, the long term biological effect of this funguson conifer trees as well as on other soil micro-flora has not been empirically proven. We investigated the impact of P. gigantea treatment on stumpmycobiota using metagenomic pyrosequencing approach as this has not been done before. Samples from forest sites pre-treated with P. gigantea for 1, 6and 13 years ago were collected, DNA was isolated and pyrosequenced. Similarly samples were also collected from untreated stumps within the sameforest sites. Sequences were quality trimmed using Mothur software. After trimming we had 26 398 sequences from 53 117. For the extraction of the fullITS1 of the nuclear ITS region <strong>Fungal</strong>ITSextractor was used and these sequences were clustered at 97% similarity using cdhit-454 with the most abundantsequence types serving as cluster seeds. The most frequent sequence type in each cluster was used for the BLAST searches against NCBI BLASTN and ³ 97%similarity across the entire length of the pairwise alignment was taken to indicate conspecificity. Differences between control and treated stumps weretested statistically with Paired-Sample T-test (SPSS 19). Also diversity indexes and similarity indexes between controls and treated were calculated usingEstimates 8.2.0. After one year of the clear-cut we found from Phlebiopsis gigantea-treated stumps 107 different fungal OTUs and from non-treatedstumps 119 fungal OTUs, from which they shared 102 OTUs. After 6 years we observed from treated stumps 118 fungal OTUs and from non-treated 134fungal OTUs and they shared 99 OTUs. After 13 years we found from treated stumps 131 OTUs and from non-treated 139 OTUs and shared OTU numberwere 109. However there were no statistical differences between control and treatment. Based on our results our primary conclusion is that stumptreatment should continue as there is no obvious adverse effect on the other stump mycobiota.703. Diversity of yeast and mold species in different cheeses. Nabaraj Banjara 1 , Kenneth Nickerson 2 , Heather Hallen-Adams 1 . 1) Food Science andTechnology, University of Nebraska-Lincoln, Lincoln, NE; 2) Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE.The yeast and mold diversity from different commercial cheeses collected from local markets (Lincoln, NE, USA) was studied using microbial counting andmolecular biology approaches. Twenty one distinct types of cheese samples were investigated. Briefly, 10 grams of each cheese sample was homogenizedin distilled water, serially diluted from 10 to 10 -6 , grown in Yeast Extract Glucose Chloramphenicol Agar (YGC) and the population was counted fromdilution plates. Yeasts and molds were identified by amplification and sequence analysis of the nuclear ribosomal RNA genes, using ITSIF and TW13primers. Debaryomyces hansenii was the predominant fungal species in most of the cheeses (59% of samples at up to 5.7 x 10 6 CFU/ gram). Other fungiisolated included D. fabryi, D. prosopidis, D. subglobosus, Penicillium roqueforti and Candida sake. In our samples, farmstead cheese had the highest (2.1 x10 8 CFU/gram) and Swiss cheese the lowest (8x10 3 CFU/gram) fungal population.704. Heterologous expression and characterization of soil organic matter-specific proteases secreted by the ectomycorrhizal fungus Paxillus involutus.Morten N. Grell 1 , Linas Pupelis 1 , Tomas Johansson 2 , Firoz Shah 2 , Lene Lange 1 , Anders Tunlid 2 . 1) Section for Sustainable Biotechnology, Department ofBiotechnology, Chemistry and Environmental Engineering, Aalborg University Copenhagen, Denmark; 2) Microbial Ecology Group, Department of Biology,Lund University, Sweden.Paxillus involutus (Batsch) Fr. (Basidiomycetes; Boletales) is widely distributed in the Northern hemisphere, and is one of the best-studiedectomycorrhizae fungi, especially with respect to its ecology and physiology. In a study on the mechanisms by which Paxillus involutus degrade complexorganic matter extracted from plant litter material, transcriptomes were sequenced using the 454 technology and NimbleGen microarrays produced. Anumber of genes encoding extracellular enzymes showed an increased transcript level during degradation of soil organic matter (SOM), as compared withgrowth on a defined medium (MNM). They were suggested to constitute a Fenton-like, radical-based biodegradation system that disrupts the organicmatter-protein complexes thereby mobilizing embedded nitrogen (Rineau et al. 2012, Environm. Microbiol. 14, 1477-1487). Supporting this, a number ofprotease genes were found to have a significantly increased SOM/MNM expression value and to be upregulated during growth on protein-rich substrates.Most highly expressed were aspartic, metallo, and serine proteases. This is in agreement with biochemical analysis of SOM degradation. To study substratespecificity and regulation of selected proteases in detail these are expressed in the yeast Pichia pastoris.705. Effector proteins in fungal defense against fungivorous nematodes: Targets and functional significance. Therese Wohlschlager 1 , StefanieSchmieder 1 , Alex Butschi 2 , Paola Grassi 3 , Alexander Titz 4 , Stuart Haslam 3 , Michael Hengartner 2 , Markus Aebi 1 , Markus Künzler 1 . 1) Institute of Microbiology,ETH Zürich, Switzerland; 2) Institute of Molecular Life Sciences, University of Zürich, Switzerland; 3) Division of Molecular Biosciences, Imperial College,London, United Kingdom; 4) Department of Chemistry, University of Konstanz, Germany.The defense of fungi against fungivores is largely based on the production of intracellular toxins. A significant proportion of these toxins are peptides andproteins that are synthesized by the ribosome and stored in the cytoplasm. Protein toxins include lectins that target specific glycoepitopes in the intestineof the fungivore upon ingestion and kill the fungivore by a yet unknown mechanism. In our laboratory, we focus on the functional characterization offungal protein toxins that are directed against nematodes. We use the model nematode Caenorhabditis elegans to identify the targets and to study thetoxicity mechanism of these fungal defense effector proteins in the nematode. In addition, we employ the fungivorous nematodes Aphelenchus avenaeand Bursaphelenchus willibaldi to study the diversity, the functional significance and the transcriptional regulation of these proteins in the fungus.Recently, we identified a nematotoxic lectin from the mushroom Laccaria bicolor that is homologous to animal lectins involved in innate immunity againstbacteria. We found that the nematotoxicity of the lectin is based on its specific binding to methylated fucose residues on nematode N-glycans. Amonganimals, this epitope is only present in worms and molluscs but not in insects or vertebrates. We performed affinity chromatography of C. elegans wholeworm protein extracts using the L. bicolor lectin and other nematotoxic fungal lectins recognizing protein-bound glycans. The results of this analysissuggest that these lectins target the same set of glycoproteins in the nematode intestine and may confer toxicity by a common mechanism. In order toaddress the functional significance of these proteins for fungal defense against fungivorous nematodes, we expressed some of the fungal proteinsdisplaying toxicity towards C. elegans, in the filamentous ascomycete Ashbya gossypii. These transformants were fed to A. avenae and the propagation ofthe fungivorous nematode on the various transformants was determined. Expression of some effector proteins significantly inhibited propagation of thenematode suggesting that these proteins have a role in fungal defense against these organisms. Experiments addressing the relative fitness of the variousA. gossypii transformants upon selective pressure of feeding by A. avenae are under way.706. Microfluidic platforms for monitoring interactions between fungi and bacteria. Martina A. Stöckli 1 , Claire E. Stanley 2 , Pauli T. Kallio 1 , MarkusKünzler 1 , Andrew J. deMello 2 , Markus Aebi 1 . 1) Microbiology and Immunology, ETH Zurich, Zurich, Switzerland; 2) Chemistry and Applied Biosciences, ETHZurich, Zurich, Switzerland.Bacteria and fungi share many microhabitats where they interact with each other. These interactions are diverse and play important roles in certainhuman infections, as well as in the biological control of plant diseases. The basis of these interactions, however, is not well understood, as theirinvestigation is technically challenging. Conventional microscopic approaches are limited, in that they can only monitor interactions at a particular time294
FULL POSTER SESSION ABSTRACTSpoint and are not able to follow dynamic interactions. Herein, the development of a microfluidic platform, to study the interplay of individual hyphae withbacteria in a confined compartment, is detailed. A microfluidic device, comprised of single, interconnected microchannels, is filled with medium. Thedevice is manufactured from the polymer, polydimethylsiloxane, which is bonded to a glass layer. Importantly, this polymer possesses some desirablecharacteristics, making it compatible with experiments of biological nature, for example it is oxygen permeable, and allows optical detection from 240 nmto 1100 nm. The fungus can easily grow into the microchannels from an agar plug that is placed next to a lateral opening. Subsequently, the device can beco-inoculated with bacteria through a separate inlet, allwoing changes in morphology, growth rate, and interaction patterns of the same hyphae upon theaddition of bacteria to be investigated over time. As an example, the interaction of the basidiomycetous model organism, Coprinopsis cinerea, and thegram-positive bacterium, Bacillus subtilis, which are both found in dung of herbivores, has been studied. Using these microfluidic platforms, it has beenobserved that B. subtilis cells attach to hyphae in an end-on manner. The frequency of attachment within hyphae and between different hyphae varies.Furthermore, the tips of the hyphae are not colonised by the bacterial cells. In summary, this approach can be used to study phenotypic changes ofbacteria and fungi over specific time periods. In future, it is envisaged that this data will be combined with fungal and bacterial genetic approaches.707. WITHDRAWN708. The French Fusarium Collection: a living resource for mycotoxin research. L. Pinson-Gadais, M. Foulongne-Oriol, N. Ponts, C. Barreau, F. Richard-Forget. INRA, UR1264-MycSA, 71 avenue Edouard Bourlaux, F-33883 Villenave d’Ornon, France.Fusaria are responsible for prejudicial diseases on cereal crops worldwide, such as crown rot and Fusarium head blight. Beyond economic losses due toinfection symptoms, these pathogens can produce several types of mycotoxins that are harmful to livestock and humans. They are extremely diverse atthe intra-specific levels in terms of types as well as quantities of toxins that a strain can produce. Developing appropriate strategies to limit contaminationwith Fusarium mycotoxins requires a greater knowledge about this variability. We have collected a large number of toxinogenic Fusarium strains. Ourassortment now includes about 800 strains, mostly from the species graminearum, culmorum, verticilloides, proliferatum, and temperatum. Species wereidentified based on morphology and real-time PCR. More than half of our strains were further characterized for toxin production using biochemical and/orreal-time PCR-based tools. We isolated about 70 F. graminearum strains from either wheat or maize grains originating from different French cerealproduction areas. Our results show a high representation of 15-acetyldeoxynivalenol-producing strains in our French samples. Within the samechemotype, we observe a large variability in toxin production levels. The F. graminearum strains were characterized with microsatellite markers and showa large genetic diversity. Two groups were delineated according to their genetic background, roughly corresponding to strains isolated from Europe in onehand and America in the other hand. Our results are also in agreement with the fact that only F. graminearum sensu stricto strains seem to be detected inFrance so far. The demonstrated genetic and phenotypic diversity provides a sound ground for countless downstream studies such as genetic associationand quantitative genetics to understand the determinism of toxin production. Such information should be doubtlessly considered in plant breeding effortsand other disease management strategies aimed at reducing the mycotoxin risk in food and feeds. Our collection is a valuable tool to improve ourunderstanding of toxigenic diversity in Fusarium species. It is managed through a database gathering all information collected on each strain, alreadyavailable upon request and soon publically available as a web-based interface.709. Chemical genetics: Discovery of novel fungicides and their targets in the phytopathogen Fusarium graminearum. G. Subramaniam, C. Mogg.Agriculture Canada, Ottawa, ON, Canada.Chemical genetics screen is based on the ability of small chemical molecules to bind to biological molecules and alter their function. Screening ofpharmaceutical libraries has revealed novel molecules effective against cancer and other diseases. We have adopted similar approach and identify bioactivecompounds that will block the growth and development of F. graminearum. We have developed a 96-well format to monitor the growth of F.graminearum in liquid media. The fungus is tagged with a green fluorescent protein (GFP) and the growth is monitored by the measurement offluorescence of the GFP. This format facilitates high throughput screening for small molecules that could potentially disrupt the growth of the fungus. Asproof of concept, we screened ~560 compounds from the TimTec NDL-3000 natural product collection (TimTec LLC, Newark, DE, USA) and identifiedseveral compounds with anti-Fusarium properties. One compound identified form our screen, “Antofine” was purified from Vincetoxicum rossicum andwas used in subsequent studies, to identify targets in the fungus. We used the gene deletion library of the budding yeast Sacchromyces cerevisiae toidentify targets for Antofine. GeneMANIA (http://www.genemania.org), an online multiple association network integration algorithm was used to uncoverinformation pertaining to genetic and physical interactions of these targets. Our efforts to identify targets in Fusarium against Antofine will be discussed.710. Functional characterization of an Aspergillus flavus polyketide synthase gene necessary for the synthesis of a sclerotium-specific pigment. J.W.Cary 1 , P. Harris-Coward 1 , K.C. Ehrlich 1 , P. Dowd 2 , S. Shantappa 3 , A.M. Calvo 3 . 1) US Department of Agriculture, ARS-SRRC, New Orleans, LA; 2) USDepartment of Agriculture, ARS-NCAUR, Peoria, IL; 3) Northern Illinois University, DeKalb, IL.The filamentous fungus, Aspergillus flavus, produces the toxic and carcinogenic, polyketide-derived family of secondary metabolites termed aflatoxins(AFs). In addition to the AF biosynthetic gene cluster, analysis of the A. flavus genome has identified 55 gene clusters predicted to be associated withsecondary metabolism. To date, very few of the metabolites produced by these clusters have been identified. Secondary metabolism is controlled byglobal regulators such as LaeA and VeA. In a veA knockout mutant we identified a significantly down-regulated polyketide synthase (PKS) gene belongingto cluster 27. Although the metabolite produced by this cluster was unknown, in silico cluster analysis predicted that cluster 27 would consist of the PKSgene and four other genes. qRT-PCR analysis confirmed that expression of the cluster 27 PKS (pks27) gene was down-regulated in the veA mutant.Inactivation of the pks27 gene resulted in loss of the dark pigment associated with A. flavus sclerotia. Sclerotia are survival structures produced bycondensation of mycelia and function as propagules in the field. Conidial pigmentation did not appear to be affected in the pks27 knockout strain. TLC andHPLC analysis of sclerotial extracts identified the cluster 27 metabolite as asparasone A. Insect feeding studies using wild-type and mutant sclerotiaindicated that the pigment may be acting as a feeding deterrent. To our knowledge this is the first report on the identification of a gene that encodes asclerotium-specific pigment. The pigment likely plays a role in sclerotial resistance to insect feeding and possibly other environmental stresses.711. Functional Analysis of the Pleurotus ostreatus Manganese-Peroxidase Gene Family. Tomer Salame, Doriv Knop, Dana Levinson, Oded Yarden,Yitzhak Hadar. Microbiology and Plat Pathology, Hebrew Unversity, Rehovot, Israel.Mn amendment to P. ostreatus cultures enhances degradation of recalcitrant aromatic compounds. Manganese peroxidase (MnP) isoenzymes are keyplayers in these processes. The MnP gene family is comprised of five Mn -dependent peroxidases (mnp3, 6, 7, 8 and 9) and four versatile-peroxidases(mnp1, 2, 4 and 5; VPs). In liquid medium, Mn amendment resulted in a drastic up-regulation of the predominantly expressed mnp3 and mnp9, and downregulationof mnp4. To obtain direct evidence for the role of these enzymes, we produced genetically-modified (knockout, knockdown and/or over-<strong>27th</strong> <strong>Fungal</strong> <strong>Genetics</strong> <strong>Conference</strong> | 295
- Page 1:
Asilomar Conference GroundsMarch 12
- Page 7 and 8:
SCHEDULE OF EVENTSFriday, March 157
- Page 10 and 11:
EXHIBITSThe following companies hav
- Page 12 and 13:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 14:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 17 and 18:
CONCURRENT SESSIONS SCHEDULESThursd
- Page 19:
CONCURRENT SESSIONS SCHEDULESFriday
- Page 22 and 23:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 24:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 27 and 28:
PLENARY SESSION ABSTRACTSThursday,
- Page 29 and 30:
PLENARY SESSION ABSTRACTSFriday, Ma
- Page 31 and 32:
PLENARY SESSION ABSTRACTSSaturday,
- Page 33 and 34:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 35 and 36:
CONCURRENT SESSION ABSTRACTSUnravel
- Page 37 and 38:
CONCURRENT SESSION ABSTRACTSSynergi
- Page 39 and 40:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 41 and 42:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 43 and 44:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 45 and 46:
CONCURRENT SESSION ABSTRACTSA draft
- Page 47 and 48:
CONCURRENT SESSION ABSTRACTSRegulat
- Page 49 and 50:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 51 and 52:
CONCURRENT SESSION ABSTRACTSThursda
- Page 53 and 54:
CONCURRENT SESSION ABSTRACTSThursda
- Page 55 and 56:
CONCURRENT SESSION ABSTRACTSThursda
- Page 57 and 58:
CONCURRENT SESSION ABSTRACTSThursda
- Page 59 and 60:
CONCURRENT SESSION ABSTRACTSThursda
- Page 61 and 62:
CONCURRENT SESSION ABSTRACTSThe mut
- Page 63 and 64:
CONCURRENT SESSION ABSTRACTSInnate
- Page 65 and 66:
CONCURRENT SESSION ABSTRACTSThursda
- Page 67 and 68:
CONCURRENT SESSION ABSTRACTSGenome-
- Page 69 and 70:
CONCURRENT SESSION ABSTRACTSIdentif
- Page 71 and 72:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 73 and 74:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 75 and 76:
CONCURRENT SESSION ABSTRACTSThe Scl
- Page 77 and 78:
CONCURRENT SESSION ABSTRACTSThe rol
- Page 79 and 80:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 81 and 82:
CONCURRENT SESSION ABSTRACTSCompari
- Page 83 and 84:
CONCURRENT SESSION ABSTRACTSNovel t
- Page 85 and 86:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 87 and 88:
CONCURRENT SESSION ABSTRACTSEffect
- Page 89 and 90:
CONCURRENT SESSION ABSTRACTSCommon
- Page 91 and 92:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 93 and 94:
CONCURRENT SESSION ABSTRACTSSeconda
- Page 95 and 96:
CONCURRENT SESSION ABSTRACTSSheddin
- Page 97 and 98:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 99 and 100:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 101 and 102:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 103 and 104:
CONCURRENT SESSION ABSTRACTSprocess
- Page 105 and 106:
CONCURRENT SESSION ABSTRACTSSpecifi
- Page 107 and 108:
LISTING OF ALL POSTER ABSTRACTSBioc
- Page 109 and 110:
LISTING OF ALL POSTER ABSTRACTS81.
- Page 111 and 112:
LISTING OF ALL POSTER ABSTRACTS160.
- Page 113 and 114:
LISTING OF ALL POSTER ABSTRACTS239.
- Page 115 and 116:
LISTING OF ALL POSTER ABSTRACTS322.
- Page 117 and 118:
LISTING OF ALL POSTER ABSTRACTS401.
- Page 119 and 120:
LISTING OF ALL POSTER ABSTRACTSmedi
- Page 121 and 122:
LISTING OF ALL POSTER ABSTRACTS558.
- Page 123 and 124:
LISTING OF ALL POSTER ABSTRACTS640.
- Page 125 and 126:
LISTING OF ALL POSTER ABSTRACTS723.
- Page 127 and 128:
FULL POSTER SESSION ABSTRACTS5. Cha
- Page 129 and 130:
FULL POSTER SESSION ABSTRACTS13. In
- Page 131 and 132:
FULL POSTER SESSION ABSTRACTSbioche
- Page 133 and 134:
FULL POSTER SESSION ABSTRACTS30. Me
- Page 135 and 136:
FULL POSTER SESSION ABSTRACTS38. Me
- Page 137 and 138:
FULL POSTER SESSION ABSTRACTSidenti
- Page 139 and 140:
FULL POSTER SESSION ABSTRACTSsecret
- Page 141 and 142:
FULL POSTER SESSION ABSTRACTSinvolv
- Page 143 and 144:
FULL POSTER SESSION ABSTRACTSdiploi
- Page 145 and 146:
FULL POSTER SESSION ABSTRACTSSaccha
- Page 147 and 148:
FULL POSTER SESSION ABSTRACTSresist
- Page 149 and 150:
FULL POSTER SESSION ABSTRACTS96. Ce
- Page 151 and 152:
FULL POSTER SESSION ABSTRACTS104. M
- Page 153 and 154:
FULL POSTER SESSION ABSTRACTScan ex
- Page 155 and 156:
FULL POSTER SESSION ABSTRACTSturgor
- Page 157 and 158:
FULL POSTER SESSION ABSTRACTSlike p
- Page 159 and 160:
FULL POSTER SESSION ABSTRACTSIndoor
- Page 161 and 162:
FULL POSTER SESSION ABSTRACTSlength
- Page 163 and 164:
FULL POSTER SESSION ABSTRACTSA scre
- Page 165 and 166:
FULL POSTER SESSION ABSTRACTSthen q
- Page 167 and 168:
FULL POSTER SESSION ABSTRACTS170. S
- Page 169 and 170:
FULL POSTER SESSION ABSTRACTSof sup
- Page 171 and 172:
FULL POSTER SESSION ABSTRACTSis fzo
- Page 173 and 174:
FULL POSTER SESSION ABSTRACTSgrowth
- Page 175 and 176:
FULL POSTER SESSION ABSTRACTSSeq da
- Page 177 and 178:
FULL POSTER SESSION ABSTRACTS212. T
- Page 179 and 180:
FULL POSTER SESSION ABSTRACTSCompar
- Page 181 and 182:
FULL POSTER SESSION ABSTRACTSmore g
- Page 183 and 184:
FULL POSTER SESSION ABSTRACTSmolecu
- Page 185 and 186:
FULL POSTER SESSION ABSTRACTSunexpe
- Page 187 and 188:
FULL POSTER SESSION ABSTRACTSrapid
- Page 189 and 190:
FULL POSTER SESSION ABSTRACTS260. T
- Page 191 and 192:
FULL POSTER SESSION ABSTRACTSFusari
- Page 193 and 194:
FULL POSTER SESSION ABSTRACTSScienc
- Page 195 and 196:
FULL POSTER SESSION ABSTRACTS286. G
- Page 197 and 198:
FULL POSTER SESSION ABSTRACTSincomp
- Page 199 and 200:
FULL POSTER SESSION ABSTRACTSfound
- Page 201 and 202:
FULL POSTER SESSION ABSTRACTS312. I
- Page 203 and 204:
FULL POSTER SESSION ABSTRACTSall th
- Page 205 and 206:
FULL POSTER SESSION ABSTRACTSPia La
- Page 207 and 208:
FULL POSTER SESSION ABSTRACTS335. A
- Page 209 and 210:
FULL POSTER SESSION ABSTRACTS342. F
- Page 211 and 212:
FULL POSTER SESSION ABSTRACTSThis i
- Page 213 and 214:
FULL POSTER SESSION ABSTRACTSJacobs
- Page 215 and 216:
FULL POSTER SESSION ABSTRACTScalciu
- Page 217 and 218:
FULL POSTER SESSION ABSTRACTSThe ab
- Page 219 and 220:
FULL POSTER SESSION ABSTRACTSexpres
- Page 221 and 222:
FULL POSTER SESSION ABSTRACTS394. F
- Page 223 and 224:
FULL POSTER SESSION ABSTRACTS398. U
- Page 225 and 226:
FULL POSTER SESSION ABSTRACTSthe id
- Page 227 and 228:
FULL POSTER SESSION ABSTRACTS415. A
- Page 229 and 230:
FULL POSTER SESSION ABSTRACTSAcuM b
- Page 231 and 232:
FULL POSTER SESSION ABSTRACTSdiverg
- Page 233 and 234:
FULL POSTER SESSION ABSTRACTSBck1 f
- Page 235 and 236:
FULL POSTER SESSION ABSTRACTSin the
- Page 237 and 238:
FULL POSTER SESSION ABSTRACTS455. T
- Page 239 and 240:
FULL POSTER SESSION ABSTRACTSor hos
- Page 241 and 242:
FULL POSTER SESSION ABSTRACTSfragme
- Page 243 and 244:
FULL POSTER SESSION ABSTRACTSenhanc
- Page 245 and 246:
FULL POSTER SESSION ABSTRACTSassess
- Page 247 and 248: FULL POSTER SESSION ABSTRACTSmating
- Page 249 and 250: FULL POSTER SESSION ABSTRACTScommon
- Page 251 and 252: FULL POSTER SESSION ABSTRACTSOne of
- Page 253 and 254: FULL POSTER SESSION ABSTRACTScells
- Page 255 and 256: FULL POSTER SESSION ABSTRACTSof Ave
- Page 257 and 258: FULL POSTER SESSION ABSTRACTSascaro
- Page 259 and 260: FULL POSTER SESSION ABSTRACTSis a n
- Page 261 and 262: FULL POSTER SESSION ABSTRACTSand th
- Page 263 and 264: FULL POSTER SESSION ABSTRACTSCiuffe
- Page 265 and 266: FULL POSTER SESSION ABSTRACTSon oth
- Page 267 and 268: FULL POSTER SESSION ABSTRACTScopies
- Page 269 and 270: FULL POSTER SESSION ABSTRACTSChem.
- Page 271 and 272: FULL POSTER SESSION ABSTRACTS593. C
- Page 273 and 274: FULL POSTER SESSION ABSTRACTS601. P
- Page 275 and 276: FULL POSTER SESSION ABSTRACTSE.elym
- Page 277 and 278: FULL POSTER SESSION ABSTRACTSThe de
- Page 279 and 280: FULL POSTER SESSION ABSTRACTSMicrob
- Page 281 and 282: FULL POSTER SESSION ABSTRACTSchromo
- Page 283 and 284: FULL POSTER SESSION ABSTRACTSmating
- Page 285 and 286: FULL POSTER SESSION ABSTRACTSAt the
- Page 287 and 288: FULL POSTER SESSION ABSTRACTSemerge
- Page 289 and 290: FULL POSTER SESSION ABSTRACTS666. G
- Page 291 and 292: FULL POSTER SESSION ABSTRACTSof che
- Page 293 and 294: FULL POSTER SESSION ABSTRACTSthe lo
- Page 295 and 296: FULL POSTER SESSION ABSTRACTSin the
- Page 297: FULL POSTER SESSION ABSTRACTSpotent
- Page 301 and 302: FULL POSTER SESSION ABSTRACTS716. p
- Page 303 and 304: FULL POSTER SESSION ABSTRACTSnatura
- Page 305 and 306: FULL POSTER SESSION ABSTRACTSelemen
- Page 307 and 308: KEYWORD LISTABC proteins ..........
- Page 309 and 310: KEYWORD LISThigh temperature growth
- Page 311 and 312: AUTHOR LISTBolton, Melvin D. ......
- Page 313 and 314: AUTHOR LISTFrancis, Martin ........
- Page 315 and 316: AUTHOR LISTKawamoto, Susumu... 427,
- Page 317 and 318: AUTHOR LISTNNadimi, Maryam ........
- Page 319 and 320: AUTHOR LISTSenftleben, Dominik ....
- Page 321 and 322: AUTHOR LISTYablonowski, Jacob .....
- Page 323 and 324: LIST OF PARTICIPANTSLeslie G Beresf
- Page 325 and 326: LIST OF PARTICIPANTSTim A DahlmannR
- Page 327 and 328: LIST OF PARTICIPANTSIgor V Grigorie
- Page 329 and 330: LIST OF PARTICIPANTSMasayuki KameiT
- Page 331 and 332: LIST OF PARTICIPANTSGeorgiana MayUn
- Page 333 and 334: LIST OF PARTICIPANTSNadia PontsINRA
- Page 335 and 336: LIST OF PARTICIPANTSFrancis SmetUni
- Page 337 and 338: LIST OF PARTICIPANTSAric E WiestUni